Pharmacokinetic assessment of isoniazid and acetylisoniazid in carbon tetrachloride-induced liver injury model in wistar rats (Record no. 20138)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | a |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20231122104702.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 231122b xxu||||| |||| 00| 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | AIKTC-KRRC |
Transcribing agency | AIKTC-KRRC |
100 ## - MAIN ENTRY--PERSONAL NAME | |
9 (RLIN) | 22134 |
Author | Sharma, Swati |
245 ## - TITLE STATEMENT | |
Title | Pharmacokinetic assessment of isoniazid and acetylisoniazid in carbon tetrachloride-induced liver injury model in wistar rats |
250 ## - EDITION STATEMENT | |
Volume, Issue number | Vol.15(3), Jul-Sep |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Mumbai |
Name of publisher, distributor, etc. | Wolter Kluwer |
Year | 2023 |
300 ## - PHYSICAL DESCRIPTION | |
Pagination | 139-145p. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | N-acetyl transferase 2 (NAT2) polymorphism testing could not see the light of success as a biomarker tool in tuberculosis management. Additionally, the antitubercular treatment (ATT) drug’s reintroduction regimen variations exist because of the scarcity of robust preclinical evidence on ATT drug metabolism. Objective: The experiment was planned to understand the pharmacokinetic (PK) behavior of isoniazid and acetylisoniazid (AcINH) in a Wistar rat model of acute liver injury induced by carbon tetrachloride (CCl 4 ) and preclinical drug-induced liver injury (DILI) model induced with CCl 4 + anti-Tuberculosis (TB) drugs together. Materials and Methods: Thirty rats were used for the experiment and were divided into five groups. All rats were administered a single 0.5 ml/kg CCl 4 intraperitoneal injection on day 0 to induce an animal model of DILI. Group I rats received CCl 4 alone. Groups II–V were started on additional gavage feedings of isoniazid (H) alone, H plus rifampicin (R), H plus pyrazinamide (Z), and H, R, and Z together, respectively, daily for 21 days subsequently. Isoniazid and AcINH PK assessment was accomplished on day 20 of continuous once-daily dosing. Liver function test (LFT) monitoring was done at baseline on days 1, 7, and 21. On the last day of experiments, all experimental rats were sacrificed. Results: Three-week ATT administration sustained the CCl 4 -induced LFT changes. Area under the curve (AUC) values for isoniazid and AcINH were found to be 2.24 and 1.69 times higher in the H + R group compared with the CCl 4 + H group, respectively ( P < 0.05). Isoniazid and AcINH maximum concentration (Cmax) reached the highest, while isoniazid clearance reached the lowest in the H + R group. AcINH AUC increased by double in the CCl 4 + Isoniazid+Rifampicin+Pyrazinamide (HRZ) group compared with the CCl 4 + H group ( P < 0.05). Biochemical, histological, and antioxidant changes were consistent with the new liver injury model’s development. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
9 (RLIN) | 5026 |
Topical term or geographic name entry element | PHARMACEUTICAL BIOTECHNOLOGY |
700 ## - ADDED ENTRY--PERSONAL NAME | |
9 (RLIN) | 22135 |
Co-Author | Anand, Aishwarya |
773 0# - HOST ITEM ENTRY | |
Title | Journal of pharmacy and bio allied science |
International Standard Serial Number | 0976-4879 |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
URL | https://journals.lww.com/jpbs/pages/results.aspx?txtKeywords=isoniazid |
Link text | Click here |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | |
Koha item type | Articles Abstract Database |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
School of Pharmacy | School of Pharmacy | Archieval Section | 2023-11-22 | 2023-1576 | 2023-11-22 | 2023-11-22 | Articles Abstract Database |